| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Editas Medicine, Inc. (EDIT) has 3 insiders with recent SEC Form 4 filings, including 15 buys and 4 sells. EDIT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 269.1K | $723.8K | - | |
| VP | 68.8K | $185.0K | - | |
| CFO | 15.9K | $42.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2016 | Bitterman Kevin63 | Director, 10% Owner | Sell | 500,000 | $16.80 | $8,400,000.00 | -10.7% | |
| Sep 8, 2016 | Polaris Venture Management Co. Vi, L.l.c. | 10% Owner | Sell | 500,000 | $16.80 | $8,400,000.00 | -10.7% | |
| Sep 6, 2016 | Starr Kevin P | 10% Owner | Sell | 5,890 | $15.90 | $93,665.73 | -100% | |
| Aug 23, 2016 | Glucksmann Alexandra | Chief Operating Officer | Sale+OE | 1,000 | $20.00 | $20,000.00 | -0.8% | |
| Feb 8, 2016 | Flynn James E62 | 10% Owner, Possible Member Of 10% Group | Buy | 100,000 | $16.00 | $1,600,000.00 | +11.7% | |
| Feb 8, 2015 | Viking Global Investors LP66 | 10% Owner | Buy | 2,040,814 | $0.00 | - | +43.6% | |
| Feb 8, 2015 | Viking Global Performance LLC | 10% Owner | Buy | 2,040,814 | $0.00 | - | +43.6% |